ABSTRACT
Introduction
A major challenge facing the biological sciences today is characterization of function(s) of numerous proteins identified in this, the post-genomic era. Integral to this task is the need to view proteins as dynamic, highly plastic structures, in which shape and form dictate function. This is facilitated by spatial-temporal studies, which may ultimately reveal networks and multi-ligand interactions between various biomolecules. To begin addressing such complex studies, it is pertinent to establish simple, robust systems for the ready recognition and imaging of discrete proteins within their native milieu. Towards this end, atomic force microscopy (AFM) is proving a useful tool that allows imaging of proteins in their native environment.
AFM has the potential to provide information concerning conformations of proteins that are appropriate to their natural function because they can be imaged under conditions that most likely reflect their physiological counterparts. This technique also has the advantage of requiring only small quantities of protein (as low as picomolar levels, but commonly in the order of ng-mg) and manipulation of the sample environment is relatively easy to achieve in order to potentially observe structural changes in the presence of metals, lipids, cofactors and other proteins. Importantly, AFM opens the way for directly observing biological samples which had previously proven extremely difficult to image.
A number of studies have used AFM to image protein structure and stoichiometry [1] [2] [3] [4] . AFM imaging has also been employed to visualize the organization of bacterial photosynthetic membranes and has provided the first view of a multi-component membrane, revealing the relative positions and associations of the photosynthetic complexes [5] . This technique has also been used to provide insights into aberrant protein polymerisation into amyloid fibrils that occurs in diseases such as Alzheimer's and type II diabetes [6, 7] .
In the current study, we used liquid cell AFM to image protein samples in an aqueous environment, thereby capturing them in a native soluble structure. The proteins used were from two distinct protein families, the S100 and CLIC family of proteins, specifically CLIC1, S100-A8, S100A9 and S100A12. These proteins share certain similarities including their expression by cells of the immune system (although not exclusively), their relatively small sizes, 10-27 kDa, and their known association with cell membranes (except for S100A12).
Background
The CLIC family consists of 6 proteins in humans (designated CLIC1-6), which form part of the glutathione-S-transferase (GST) superfamily [8, 9] . They are highly conserved in vertebrates, with related proteins in invertebrates [10] . They have a conserved C-terminal 240 residue module and one major transmembrane domain. The distribution and intracellular localisation of these proteins is distinct for each family member [11] . All members can invoke chloride ion channel activity, and it is proposed that the proteins themselves form ionconducting channels in membranes [8, [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] . In order to perform this function, these proteins must move from their soluble form to a transmembrane complex. It remains unclear how this translocation is regulated in vivo and to date, no transmembrane structures of these proteins have been elucidated.
Structural studies on CLIC proteins have focused on CLIC1 and CLIC4. Structures of the soluble forms were determined by X-ray crystallography [9, 10] . Soluble CLIC1, first isolated from activated macrophage cells [20] , is a monomer and has a GST fold with a covalent binding site for glutathione [9] . Oxidation causes a major conformational change that is stabilized by non-covalent dimerization [15] . Soluble CLIC4 is also a monomer and is structurally similar to CLIC1 [10] but oxidation does not stabilize the radical conformational change that is observed in CLIC1 [10] .
The S100 proteins are highly homologous, low molecular weight (10-14 kDa), calcium modulated proteins belonging to the EF hand superfamily [21] . Several are over-expressed in tumour cells and have been used as markers for tumour classification [22] . S100 proteins are involved in vital intra-and extracellular processes [23, 24] including; modulation of cell growth, migration and differentiation, regulation of intracellular signal transduction/phosphorylation pathways, energy metabolism, cytoskeletal-membrane interactions [25, 26] , fatty acid transport [23, 27] and modulation of ion channels [28] .
The three "myeloid-associated" S100 proteins S100A8, S100A9, S100A12 (A8, A9, A12 respectively) are expressed constitutively in large amounts by neutrophils (together they constitute approximately 45% of total neutrophil cytoplasmic protein) and are induced in monocytes/macrophages [29] , endothelial cells [30] , keratinocytes [31, 32] and fibroblasts [33] , by a variety of mediators that regulate inflammation. A8 and A9 form a noncovalent complex known as calprotectin, which is implicated in neutrophil defence, by virtue of its anti-microbial activity, which is dependent on the Zn 2+ -binding capacity of A9 [34] . The complex also causes apoptosis of lymphocytes by uptake of extracellular Zn 2+ [35] . The A8/A9 complex is lipophilic and intracellularly is a major transporter of unsaturated fatty acids and arachidonic acid [27] . At low levels of intracellular Ca 2+ typical of resting cells, A8 and A9 are primarily located in the cytosol but following elevation of [Ca 2+ ] i generated by cell activation, they translocate to membranes and cytoskeletal components such as vimentin, in neutrophils and monocytes [26, 36] .
The crystal structure of these S100 proteins has been determined [37] [38] [39] ; all appear to exist in cells as their preferred structure of either non-covalently attached homo-or heterodimers [24] . In A12, the crystal structure of the Cu
2+
-bound form indicates a complex of 3 dimers [40] and multimer A12-Zn 2+ complexes are found in human atherosclerotic plaque [41] , A8 and A9 form heterocomplexes in the presence or absence of calcium and the quatramer may be the preferred functional form [42] . The crystal structure of the A8/A9 heterocomplex is not reported. We recently described the first AFM liquid cell images of the A8/A9 heterocomplex, along with images of its interaction with artificial lipid membranes [43] . An earlier AFM study of interactions between the soluble A8/A9 complex and cytochrome b 558 was performed using dried samples, imaged in air [44] . The S100 proteins have properties similar to the CLIC proteins in terms of their oligomerisation and interactions with lipid membranes.
In the current study we successfully imaged four distinct proteins by liquid cell AFM-S100A8, S100A9, S100A12 and CLIC1. Their dimensions determined by AFM measurement were found to be in agreement with calculated molecular volumes and X-ray crystallography structural dimensions. In addition, the effect of oxidation on the oligomeric state of the protein, CLIC1, was investigated and shown to be redox sensitive.
Methods

General Reagents and Protein Production
Reagents and chemicals used were analytical grade (Sigma, Bio-Rad). Recombinant S100A8, S100A9 and S100A12 were produced and purified using the pGEX-4T-1 expression system as previously described [45, 46] . Recombinant CLIC1 protein was produced and purified using the pGEX-4T-1 vector expression system as previously described [15] CLIC protein was stored in buffer containing 1 mM of the reducing agent dithiothreitol (DTT).
Atomic Force Microscopy
All images were acquired in buffer at room temperature using a Nanoscope IIIA MultiMode AFM equipped with an Extender™ electronics module (Veeco Instruments, Santa Barbara, CA, USA). An E type scanner was used, having a maximum scan area of 12.5 µm 2 and vertical height range of 3.4 µm. The NP-S series of narrowlegged, V-shaped, 100 µm long oxide-sharpened silicon nitride cantilevers, with integrated tips (Veeco Instruments) and a nominal spring constant, k, of 0.36 N/m were used. The AFM was driven in 'Tapping mode™' (TM-AFM) at the typical cantilever resonance frequency (near 9 kHz) in a liquid cell environment at ambient temperature. The piezo Z range was reduced to around 500 nm whilst scanning. The scan speeds ranged from 1 to 4 Hz with high gains deployed throughout. The MultiMode AFM is isolated from acoustic noise by an isolation chamber and from mechanical vibration by bungee shock cord suspension.
For imaging, proteins were diluted in working buffer (140 mM KCl, 10 mM Hepes, 0.1 mM CaCl 2 , pH 6.5) to a final concentration of 1 mg/mL. The protein (50 µL) was then spotted onto a circular disc of freshly cleaved mica (ProSciTech) that had been super-glued to hydrophobic waxy parafilm (ProSciTech), which was in turn super-glued to a 12 mm magnetic metal disc (which attaches to the sample holder of the Multimode AFM). The protein samples were then placed under a small Petri dish for 15 minutes with distilled water spread around the perimeter in order to saturate the environment and minimise evaporation. The protein sample was then rinsed 3 times with 100 µL of working buffer, with a final 50 µL of working buffer added prior to mounting the disc on the AFM.
Oxidation Experiments
To examine the effect of hydrogen peroxide treatment on CLIC1, a 20 mM stock solution of hydrogen peroxide was prepared immediately before use then added to give a final concentration of 2 mM to typically 20-50 ul of the purified protein (2 mg/ml) in 140 mM KCl, 10 mM Hepes, 0.1 mM CaCl 2 , pH 6.5 and incubated overnight at +4˚C. After incubation the protein was prepared for AFM imaging as described above.
Image Analysis
Measurements of protein "spots" on mica substrate were carried out using Nanoscope IIIA software (Veeco Instruments, Santa Barbara, CA, USA). The cross-section tool was used to measure the height (h) and the diameter (d) at half-maximal height of the proteins. This was done in order to compensate for the artificially induced overestimation of the protein width. Samples with dimensions <0.5 nm were disregarded as they were deemed too small to represent intact protein. The Experimental Molecular Volume (V Exp ) of the proteins was calculated using the following formula which calculates the volume of a spherical cap [1] :
(1) Where h and r are the height and radius of the protein particle, respectively.
The Molecular Volume based on molecular weight (V Cal ) was calculated using the following equation: 
Results
AFM Imaging of the S100 Proteins in Buffer
Imaging of the S100 proteins was undertaken in buffer using tapping-mode, liquid-cell AFM. The 3 proteins were imaged individually under the same conditions at room temperature. Images collected were from at least 3 independent preparations of the protein samples spotted onto mica on different days. All 3 proteins gave unique error mode images and protein heights and widths were easily discernable from the cross section images (Figures  2-4) . It was found that the populations of protein particles were heterogeneous in size. Molecular volumes were calculated for each protein {S100A8 (n = 44); S100A9 (n = 24); S100A12 (n = 52)}, using Equation 1 (Methods) and a frequency distribution of volumes was produced (see Figure 1) . Molecular volumes representing large aggregates of protein were excluded from the frequency distribution data. S100A8 (comprises 93 amino acids; mass, 10834.51 Da) adsorbed onto mica formed spherical cap-shaped spots, of heterogeneous size, ranging from 1.2 to 3.5 nm in height and 7.0 to 16.2 nm diameter (at half height). Figure 2 , panel B, is the image of a representative S100A8 spot with dimensions measuring 8.2 nm diameter (at half height) and a height of 1.5 nm. Using these dimensions, the experimental molecular volume is 41.4 nm 3 . The X-ray crystal structure reported by Ishikawa et al (2000) demonstrated that the protein in solution exists Figure 1 . Frequency distributions of the experimental molecular volumes of the proteins (A)S100A8; (B)S100A9 and (C)S100A12. The molecular volumes are determined from the dimensions taken from individual protein "spots". In the case of the S100A9 protein, the dimensions were taken from one lobe of the tetramer structure when it appeared in this configuration and reported as the volume of each individual lobe.
as a non-covalently linked dimer [37] . Assuming that the spot imaged represented a dimer, then the experimental molecular volume for the monomer would be 20.7 nm 3 , similar to the calculated molecular volume of S100A8, which is 21 nm 3 , calculated from its molecular weight. S100A9 has a molecular mass of 13241.99 Da and comprises 114 amino acid residues. The X-ray crystal structure [38] of soluble S100A9 carried out in the presence of Chaps detergent indicates a tetramer structure of four S100A9 dimers. Our AFM imaging resolved these four dimers, which came together in a distinct cloverleaf-like structure (Figure 3, Panels (a)-(c) ).
The dimensions of a single S100A9 dimer within the tetramer structure was approximately 11.8 nm wide by 0.95 nm high, giving an experimental molecular volume for the monomer as 26.2 nm 3 , which agrees favourably with the calculated molecular volume of S100A9 monomer of 25 nm 3 . AFM images of S100A12 (Figure 4) , also revealed a range of spherical structures ranging in size from 0.6 to 2.53 nm in height and 9.0 to 27.5 nm in diameter. The Xray crystal structure of this protein, determined in 2001 by Moroz et al. [47] , indicates that soluble S100A12 (mass, 10575.04 Da comprising 92 amino acids) also exists as a homodimer. However, it also forms quatram- ers and hexomers, particularly in the presence of Zn 2+ [41, 48] . The hexamer structure determined by X-ray crystallography, is reported to be arranged as a trimer of dimers in a spherical assembly, with an external diameter of about 5.5 nm with a central hole of 1 nm diameter [48] , and represented in Figure 4 , Panel (d). Figure 4 , Panel (e), shows the dimensions of a representative protein spot with dimensions of 14.7 nm diameter (at half height) and height of 1.4 nm. Using these dimensions, the experimental molecular volume would be 120.25 nm 3 . Assuming a hexamer structure, the S100-A12 monomer has a volume of 20.0 nm 3 ; the calculated molecular volume determined from the mass of S100A12 monomer is 20 nm 3 .
AFM Imaging of CLIC1 in Buffer
CLIC1 (mass, 26922.73 Da, comprising 241 amino acids) was imaged in buffer in its reduced form or following oxidation with hydrogen peroxide, as described in the methods ( Figure 5) . The height and diameter at halfheight for the individual protein particles was measured and molecular volumes calculated {reduced CLIC1 (n = 96); oxidised CLIC1 (n = 136)}. The population of particles was found to be heterogeneous in size. A frequency distribution of the molecular volumes of reduced CLIC1 particles (Figure 6(a) ) demonstrated that >50% had a molecular volumes between 50-100 nm 3 ; approximately 36% of the particles had a size of 50 nm 3 (smallest particle sizes). Molecular volumes representing large aggregates of protein were excluded from the frequency distribution data. Under oxidising conditions, the frequency distribution of the protein particle sizes (Figure 6(b) ) changed dramatically, with <5% having a molecular volume of 50 nm 3 . Using the mass of CLIC1, the calculated molecular volume of a monomer is 51 nm 3 .
Discussion
We have shown that the calculated molecular volume of 4 distinct proteins using AFM measurements, correspond to the volume of the proteins calculated from their respective molecular weight. The images of the soluble oligomeric structures of these proteins was also found to correspond to structures determined by X-ray crystallography for each of these proteins [9, 15, [37] [38] [39] 48] and reported in the protein database, confirming that AFM can reliably interpret quaternary protein structure. Based upon the measured height and diameter values obtained from the AFM images, single subunit volumes could be discerned, along with multimer configurations of the proteins. Because CLIC1 protein structure has been shown to be redox sensitive [15] , we also imaged soluble CLIC1 under oxidising conditions. SDS-PAGE and western blotting experiments also confirm that CLIC1 is a monomer under reduced conditions and forms oligomers under oxidising conditions (results not shown). Our current data clearly demonstrate by independent means, the oligomerisation of CLIC1 following its exposure to the strong oxidant, H 2 O 2 . From the X-ray crystallography studies [15] it is known that the dimer is produced as a result of a major conformational change in the N-domain of the protein, which includes the formation of an intramolecular disulfide bond between Cys-24 and Cys-59. This rearrangement in the N-domain results in the loss of the -sheet found in the monomer. The dimers interact principally through 2 hydrophobic flat sheets, consisting of 4-helices [15] . This dimer structure may act as an intermediary in the soluble milieu, which stabilises the protein by allowing the exposed hydrophobic faces of the monomers to interact. However, in the presence of a membrane, it is postulated that this hydrophobic domain of CLIC1 may interact directly with, and lead to membrane insertion of the protein [15] .
We have now also established a technique for incorporating CLIC1 into artificial membranes by incubating liposomes with CLIC1 under oxidising conditions (data not shown here). Using a combination of such methods along with the AFM imaging, it is envisaged that the transmembrane form of CLIC1 can be deduced, along with its oligomeric state within the membrane. Similarly, the membrane forms of the S100 proteins can similarly be investigated, in order to shed further light on the role and regulation of these proteins when located at cellular membranes.
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